Serum Levels of Aryl Hydrocarbon Receptor Plasma Agonist Activity Are Reduced in Patients With NMOSD and Correlate With Disease Activity
Related Posts
Mackow NA, Shao W, Ge L, Komarow L, Jiang J, Boutzoukas A, Chen L, Garcia-Diaz J, Herc ES, Doi Y, Arias CA, Albin O, Saade[...]
Rhee CM, Zisman-Ilani Y, Kalantar-Zadeh K, Nguyen DV. Continuous glucose monitoring in patients with chronic kidney disease on dialysis and with kidney transplantation. Curr Opin[...]
Lobo AS, Vaughan L, Ainsworth AJ, Felt M, Elali I, Arriola-Montenegro J, Garovic VD, Kattah AG. Sex hormones and sexual health in chronic kidney disease[...]